Published in Ann Rheum Dis on May 01, 1988
Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1991) 0.95
Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann Rheum Dis (1995) 0.90
Heat-induced aggregated human IgG modifies the adherence of human polymorphonuclear cells to cultured endothelium. Clin Exp Immunol (1989) 0.79
Morphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.77
An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol (1986) 5.14
Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol (1986) 3.35
Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest (1975) 2.40
Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG. J Immunol (1984) 1.05
Leucocyte function in patients with rheumatoid arthritis: quantitative in-vivo leucocyte mobilisation and in-vitro functions of blood and exudate leucocytes. Ann Rheum Dis (1985) 0.99
Rheumatoid blood decreases the adherence of polymorphonuclear cells (PMNs) to cultured endothelium. Ann Rheum Dis (1987) 0.91
The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol (1993) 9.69
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2006) 5.78
BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci (2001) 4.54
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother (1999) 4.36
Lens opacities classification system II (LOCS II) Arch Ophthalmol (1989) 4.17
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Public disclosure of health care performance reports: experience, evidence and issues for policy. Int J Qual Health Care (1999) 2.98
Signal probability, reinforcement and signal detection. J Exp Anal Behav (1979) 2.45
Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1978) 2.32
Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect (2003) 2.29
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Independence of sensitivity to relative reinforcement rate and discriminability in signal detection. J Exp Anal Behav (1980) 2.16
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience (1987) 2.05
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Therapeutic beds: the Trojan horses of the 1990s? Lancet (1994) 1.96
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
On the discriminability of stimulus duration. J Exp Anal Behav (1980) 1.91
The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr (2012) 1.88
A method of preparing blood leucocytes for flow cytometry which prevents upregulation of leucocyte integrins. J Immunol Methods (1992) 1.86
Transformation of Haemophilus influenzae by plasmid RSF0885 containing a cloned segment of chromosomal deoxyribonucleic acid. J Bacteriol (1981) 1.86
Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am J Physiol Regul Integr Comp Physiol (2003) 1.86
Genetic transformation system in the archaebacterium Methanobacterium thermoautotrophicum Marburg. J Bacteriol (1988) 1.85
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2004) 1.85
Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. J Clin Microbiol (1994) 1.85
Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84
Botulinum toxin type a for dysthyroid upper eyelid retraction. Ophthal Plast Reconstr Surg (2004) 1.77
Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis (1995) 1.74
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med (1991) 1.67
Localization of enzymes and alkaloidal metabolites in Papaver latex. Arch Biochem Biophys (1983) 1.67
Separation of human tissue alkaline phosphatases by electrophoresis on acrylamide disc gels. Clin Chim Acta (1968) 1.66
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Isobias and alloiobias functions in animal psycophysics. J Exp Psychol Anim Behav Process (1984) 1.60
The effects of message framing and ethnic targeting on mammography use among low-income women. Health Psychol (2001) 1.57
Towards a behavioral theory of bias in signal detection. Percept Psychophys (1981) 1.57
Delayed signal detection, differential reinforcement, and short-term memory in the pigeon. J Exp Anal Behav (1984) 1.56
Transcaruncular approach to the medial orbit and orbital apex. Ophthalmology (2000) 1.52
Transformation of Haemophilus influenzae by plasmid RSF0885. J Bacteriol (1981) 1.51
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
The interaction of stimulus and reinforcer control in complex temporal discrimination. J Exp Anal Behav (1987) 1.49
Reinforcement for errors in a signal-detection procedure. J Exp Anal Behav (1980) 1.48
TNFα from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis. Am J Transplant (2013) 1.46
The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures. J Rheumatol (1996) 1.46
Lens Opacities Classification System. Arch Ophthalmol (1988) 1.46
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Closing volume in asymptomatic asthma. Am Rev Respir Dis (1973) 1.43
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Intrinsically stable IgG aggregates. J Immunol Methods (1981) 1.41
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma. Lancet (1989) 1.38
Delayed matching-to-sample performance: Effects of relative reinforcer frequency and of signaled versus unsignaled reinforcer magnitudes. J Exp Anal Behav (1995) 1.37
Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology (1999) 1.37
A plasmid cloning vehicle for Haemophilus influenzae and Escherichia coli. J Bacteriol (1982) 1.35
Independence of stimulus discriminability from absolute rate of reinforcement in a signal-detection procedure. J Exp Anal Behav (1982) 1.35
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Measures of response bias at minimum-detectable luminance levels in the pigeon. J Exp Anal Behav (1983) 1.25
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Regional lung function in patients with hepatic cirrhosis. J Clin Invest (1971) 1.23
A review of recent advances in optical fibre sensors for in vivo dosimetry during radiotherapy. Br J Radiol (2015) 1.23
Gyrase-dependent initiation of bacteriophage T4 DNA replication: interactions of Escherichia coli gyrase with novobiocin, coumermycin and phage DNA-delay gene products. J Mol Biol (1979) 1.21
Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol (1978) 1.20
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res (1991) 1.16
DNA elongation rates and growing point distributions of wild-type phage T4 and a DNA-delay amber mutant. J Mol Biol (1976) 1.16
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
Evaluation of chromogenic media for the isolation of vancomycin-resistant enterococci from stool samples. Lett Appl Microbiol (2009) 1.15
Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthal Plast Reconstr Surg (2000) 1.14
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
Sequence of the rec-2 locus of Haemophilus influenzae: homologies to comE-ORF3 of Bacillus subtilis and msbA of Escherichia coli. Gene (1994) 1.14
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Immunoflorescence studies of Leishmania enriettii infection in the guinea pig. Trans R Soc Trop Med Hyg (1974) 1.11
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol (1996) 1.11
Peripheral leucocyte migration. Inhibited by diphtheroid organisms isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1970) 1.10
The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy. Clin Exp Immunol (1971) 1.09
Effects of relative reinforcer frequency on complex color detection. J Exp Anal Behav (1989) 1.09
Osteomalacia and coeliac disease presenting as isolated dactylitis. Ann Rheum Dis (1988) 1.08
Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA (1973) 1.07
Sewage pollution in urban stormwater runoff as evident from the widespread presence of multiple microbial and chemical source tracking markers. Sci Total Environ (2013) 1.06
Plasmid recombination in Haemophilus influenzae. J Mol Biol (1982) 1.06
Anti-RANA antibody: a marker for seronegative and seropositive rheumatoid arthritis. Lancet (1980) 1.06
Simultaneous measurements of the accumulation of isotope-labelled protein and erythrocytes in skin reactions of allergic inflammation in the guinea-pig. Immunology (1972) 1.05
Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res (1994) 1.05
Cognition and behavior analysis. J Exp Anal Behav (1989) 1.04
Delayed reinforcement and delayed choice in symbolic matching to sample: Effects on stimulus discriminability. J Exp Anal Behav (1986) 1.04
Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J Pathol (1982) 1.03
Evaluation of cyclohexenoesculetin-beta-D-galactoside and 8-hydroxyquinoline-beta-D-galactoside as substrates for the detection of beta-galactosidase. Appl Environ Microbiol (1996) 1.02
An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography. J Immunol Methods (1987) 1.02
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol (1994) 1.00
A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis. Br J Ophthalmol (1988) 1.00
Do vitamin D supplements improve the physical capabilities of elderly hospital patients? Age Ageing (1985) 1.00